Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
₹20 Cr
P/E Ratio
61.86
P/B Ratio
1.97
Industry P/E
36.66
Debt to Equity
1.28
ROE
4.25 %
ROCE
7.91 %
Div. Yield
0 %
Book Value
15.89
EPS
0.51
CFO
₹-14.84 Cr
EBITDA
₹14.21 Cr
Net Profit
₹5.08 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Zenlabs Ethica
| -20.40 | 3.99 | -12.26 | -23.76 | -2.76 | -1.37 | -- |
|
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Small Cap
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Zenlabs Ethica
| -4.10 | -17.53 | 50.98 | 1.22 | -12.47 | -39.49 | 0.25 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 430.45 | 7,004.90 | 25.53 | 12.5 | |
| 5,218.00 | 8,680.23 | 36.69 | 43.77 | |
| 668.50 | 6,569.59 | 74.41 | 4.01 | |
| 745.45 | 6,001.20 | 34.39 | 20.28 |
No Review & Analysis are available.
Wholesale of pharmaceutical and medical goods
Incorporated
1993
Chairman
--
Managing Director
Sanjeev Kumar
Headquarters
Chandigarh, Union Territory
Website
Looking for more details about Zenlabs Ethica Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Zenlabs Ethica Ltd stood at ₹ 40 Cr as on 31-Dec-24
The share price of Zenlabs Ethica Ltd is ₹31.26 (BSE) as of 17-Apr-2025 IST. Zenlabs Ethica Ltd has given a return of -2.76% in the last 3 years.
Zenlabs Ethica Ltd has a market capitalisation of ₹ 20 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Zenlabs Ethica Ltd is 1.97 times as on 17-Apr-2025, a 62% discount to its peers’ median range of 5.12 times.
The P/E ratio of Zenlabs Ethica Ltd is 61.86 times as on 17-Apr-2025, a 69% premium to its peers’ median range of 36.66 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Zenlabs Ethica Ltd and enter the required number of quantities and click on buy to purchase the shares of Zenlabs Ethica Ltd.
Wholesale of pharmaceutical and medical goods
The prominent promoters of Zenlabs Ethica Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
PREET REMEDIES LIMITED |
26.58%
|
|
SANJAY DHIR |
13.18%
|
|
SANJEEV KUMAR SINGAL |
13.17%
|
The chairman of the company is , and the managing director is Sanjeev Kumar.
There is no promoter pledging in Zenlabs Ethica Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
8,577
|
|
|
6,871
|
|
|
6,260
|
|
|
5,723
|
| Zenlabs Ethica Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
3.23
|
|
Operating margin(%)
|
2.6
|
|
Net Margin(%)
|
0.61
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Zenlabs Ethica Ltd was ₹0 Cr.
₹-0.74
(
